An op-ed in Townhall referenced CAHC’s research on rising Medicare Part D premiums.
The Council for Affordable Health Coverage says premiums could skyrocket another 50% in the next year. Nearly two decades of stability, and now an explosion in prices and a $3 billion-per-year new federal bureaucracy to continue to meddle in America’s prescription drug industry in a way that benefits big insurance companies but not the companies that develop life-saving drugs and certainly not consumers.